Utama › Kanser Ginjal › Missouri › St. Louis
Kajian klinikal Kanser Ginjal di St. Louis, MO
9 kajian untuk Kanser Ginjal sedang mencari peserta di lokasi dalam dan sekitar St. Louis (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.
Teks kajian rasmi (Bahasa Inggeris)
Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →
A Study of HC-7366 in Combination With Belzutifan (WELIREG™) in Patients With Renal Cell Carcinoma
Mengambil pesertaFasa 1
- Washington University School of Medicine, St Louis
Study of Orellanine in Metastatic Clear-Cell or Papillary Renal Cell Carcinoma
Mengambil pesertaFasa 1/2
- Washington University in St. Louis, St Louis
Study of Casdatifan and Cabozantinib Versus Placebo and Cabozantinib in Patients With Advanced Clear Cell Renal Cell Carcinoma
Mengambil pesertaFasa 3
- Research Site, St Louis
Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
Mengambil pesertaKajian pemerhatian
- Washington University, St Louis
Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer
Mengambil pesertaFasa 1/2
- Siteman Cancer Center, St Louis
- Barnes-Jewish Hospital, St Louis
- Washington University School of Medicine - Siteman Cancer Center, St Louis
- dan 5 lagi
Predicting Response to Immunotherapy From Analysis of Live Tumor Biopsies (ELEPHAS-05)
Mengambil pesertaKajian pemerhatian
- Mercy Hospital - South, St Louis
- Mercy Hospital -STL, St Louis
KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors
Mengambil pesertaFasa 1
- Washington University School of Medicine, St Louis
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Mengambil pesertaKajian pemerhatian
- Massive Bio SYNERGY-AI site, St Louis
A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression
Mengambil pesertaFasa 1/2
- Washington University, St Louis
Kajian Kanser Ginjal di bandar lain
- New York City, NY15 kajian
- Boston, MA12 kajian
- Nashville, TN12 kajian
- Houston, TX10 kajian
- San Diego, CA9 kajian
- Dallas, TX9 kajian
- Washington, DC9 kajian
- Seattle, WA8 kajian
- Edison, NJ8 kajian
- Miami, FL8 kajian
- Los Angeles, CA7 kajian
- Rochester, MN7 kajian
Kajian lain di St. Louis
- Kanser Paru-paru Bukan Sel Kecil73 kajian
- Kanser Payudara64 kajian
- Kanser Metastatik54 kajian
- Kanser Kolorektal50 kajian
- Kanser (semua jenis)46 kajian
- Kanser Prostat46 kajian
- Kanser Paru-paru39 kajian
- Kanser Ovari38 kajian
- Kanser Pankreas33 kajian
- Kanser Endometrium29 kajian
- Karsinoma Sel Skuamosa Kepala dan Leher28 kajian
- Kegagalan Jantung26 kajian
Daripada ClinicalTrials.gov, data diperoleh pada 6 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.